549-P: Understanding PCP Perspectives in a Project ECHO T1D Program Using the Consolidated Framework for Implementation Research

التفاصيل البيبلوغرافية
العنوان: 549-P: Understanding PCP Perspectives in a Project ECHO T1D Program Using the Consolidated Framework for Implementation Research
المؤلفون: Eleni Sheehan, Rayhan A. Lal, Linda G. Baer, Ashby F. Walker, Matthew J. Gurka, Brian C. Fitzgerald, Stephanie L. Filipp, Claudia Anez-Zabala, Sarah C. Westen, Marina Basina, Jessie J. Wong, Michael J. Haller, Gaia L. Zori, Xanadu Roque, Angelina Bernier, Kea Turner, David M. Maahs, Eugene Lewit, Jennifer Maizel, Nicolas Cuttriss, Lauren Figg, Korey K. Hood, Katarina Yabut, Diana Naranjo
المصدر: Diabetes. 70
بيانات النشر: American Diabetes Association, 2021.
سنة النشر: 2021
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Subspecialty, Focus group, Likert scale, Qualitative analysis, Family medicine, Health care, Internal Medicine, medicine, Intervention implementation, Implementation research, Thematic analysis, Psychology, business
الوصف: The Project Extension for Community Healthcare Outcomes (ECHO™) model addresses disparities by empowering primary care provider (PCPs), through tele-education, to meet the needs of underserved communities lacking access to subspecialty care. Given the rapid replication of this model, it is vital to understand the perspectives of participating PCPs to refine program implementation. Project ECHO™ Type 1 Diabetes (T1D) program was piloted in Florida and California with >15 Federally Qualified Health Centers (FQHC). PCPs completed pre/post-test surveys assessing knowledge and confidence in T1D care. Exit surveys and focus groups were conducted to understand their experiences (N=92 providers, 41 from FL and 51 from CA were queried). Qualitative analysis of open-ended survey feedback and thematic analysis of focus group data used the Consolidated Framework for Implementation Research (CFIR). The CFIR identifies five domains that affect intervention implementation - including internal and external factors to the healthcare organization. Pre/post surveys demonstrated significant improvements in providers’ diabetes knowledge; mean ± SD change in score for an 11-item knowledge evaluation from pre/post: (1.0 ± 1.8, [Min: -2, Max: +5], p-value: 0.0003) and increase in overall confidence evaluated on a 4-point likert scale (0.6 ± 0.4 [Min: -0.1, Max: 1.6] p-value Disclosure A. F. Walker: None. S. L. Filipp: None. K. Turner: None. G. L. Zori: None. J. Maizel: None. N. Cuttriss: Consultant; Self; Cecelia Health. L. G. Baer: None. L. Figg: None. K. K. Hood: Consultant; Self; Cecelia Health, Cercacor, LifeScan Diabetes Institute. R. Lal: Consultant; Self; Abbott Diabetes, Biolinq, Capillary Biomedical, Inc., Morgan Stanley, Tidepool. M. Basina: None. M. J. Haller: Board Member; Self; SAB Biotherapeutics, Inc., Consultant; Self; MannKind Corporation, Other Relationship; Self; Janssen Pharmaceuticals, Inc., Sanofi. J. J. Wong: None. K. Yabut: None. D. Naranjo: None. E. Lewit: None. D. M. Maahs: Advisory Panel; Self; Abbott Diabetes, Dompe, Eli Lilly and Company, Medtronic, Novo Nordisk, Consultant; Self; aditxt. E. Sheehan: None. S. C. Westen: None. C. Anez-zabala: None. X. Roque: None. B. C. Fitzgerald: None. A. Bernier: None. M. J. Gurka: None. Funding The Leona M. and Harry B. Helmsley Charitable Trust
تدمد: 1939-327X
0012-1797
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5547957eabbda1092748bfb13199061e
https://doi.org/10.2337/db21-549-p
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........5547957eabbda1092748bfb13199061e
قاعدة البيانات: OpenAIRE